Follow
Juarranz Y or Juarranz MG
Juarranz Y or Juarranz MG
Catedrática de Universidad, UCM
Verified email at ucm.es
Title
Cited by
Cited by
Year
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease
C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ...
Gastroenterology 124 (4), 961-971, 2003
2822003
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases
M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ...
Journal of molecular medicine 80, 16-24, 2002
2012002
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Y Juarranz, C Abad, C Martinez, A Arranz, I Gutierrez-Cañas, F Rosignoli, ...
Arthritis research & therapy 7, 1-12, 2005
1542005
PACAP in immunity and inflammation
M Delgado, C Abad, C Martinez, MG Juarranz, J Leceta, D Ganea, ...
Annals of the New York Academy of Sciences 992 (1), 141-157, 2003
1522003
VIP–PACAP system in immunity: new insights for multitarget therapy
RP Gomariz, Y Juarranz, C ABAD, A Arranz, J Leceta, C Martinez
Annals of the New York Academy of Sciences 1070 (1), 51-74, 2006
1512006
Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor
C Martinez, C Abad, M Delgado, A Arranz, MG Juarranz, ...
Proceedings of the National Academy of Sciences 99 (2), 1053-1058, 2002
1502002
The role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases
EM García-Cuesta, CA Santiago, J Vallejo-Díaz, Y Juarranz, ...
Frontiers in Endocrinology 10, 479052, 2019
1342019
Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP
RP Gomariz, A Arranz, C Abad, M Torroba, C Martinez, F Rosignoli, ...
Journal of leukocyte biology 78 (2), 491-502, 2005
1042005
VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts
I Gutierrez-Canas, Y Juarranz, B Santiago, A Arranz, C Martinez, ...
Rheumatology 45 (5), 527-532, 2006
1012006
Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells
MG Juarranz, B Santiago, M Torroba, I Gutierrez-Canas, G Palao, ...
Rheumatology 43 (4), 416-422, 2004
992004
IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts
M Carrion, Y Juarranz, C Martínez, I Gonzalez-Alvaro, JL Pablos, ...
Rheumatology 52 (12), 2177-2186, 2013
862013
Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction
RM Solano, I Langer, J Perret, P Vertongen, MG Juarranz, P Robberecht, ...
Journal of Biological Chemistry 276 (2), 1084-1088, 2001
852001
cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP
C Abad, Y Juarranz, C Martinez, A Arranz, F Rosignoli, M García-Gómez, ...
Inflammatory bowel diseases 11 (7), 674-684, 2005
832005
Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts
Y Juarranz, I Gutiérrez‐Cañas, B Santiago, M Carrión, JL Pablos, ...
Arthritis & Rheumatism 58 (4), 1086-1095, 2008
822008
RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide
M Carrión, Y Juarranz, S Pérez‐García, R Jimeno, JL Pablos, RP Gomariz, ...
Arthritis & Rheumatism 63 (6), 1626-1636, 2011
752011
VIP and PACAP are autocrine factors that protect the androgen‐independent prostate cancer cell line PC‐3 from apoptosis induced by serum withdrawal
I Gutiérrez‐Cañas, N Rodríguez‐Henche, O Bolaños, MJ Carmena, ...
British journal of pharmacology 139 (5), 1050-1058, 2003
712003
Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis
C Martínez, AM Ortiz, Y Juarranz, A Lamana, IV Seoane, J Leceta, ...
PloS one 9 (1), e85248, 2014
642014
Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation
J Leceta, RP Gomariz, C Martinez, M Carrión, A Arranz, Y Juarranz
Neuroimmunomodulation 14 (3-4), 134-138, 2007
632007
Pituitary adenylate-cyclase-activating polypeptide expression in the immune system
C Abad, C Martinez, J Leceta, MG Juarranz, M Delgado, RP Gomariz
Neuroimmunomodulation 10 (3), 177-186, 2002
602002
New insights into the role of VIP on the ratio of T‐cell subsets during the development of autoimmune diabetes
R Jimeno, RP Gomariz, I Gutiérrez‐Cañas, C Martínez, Y Juarranz, ...
Immunology and cell biology 88 (7), 734-745, 2010
592010
The system can't perform the operation now. Try again later.
Articles 1–20